AD-221

AD-221 · Addpharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AD-221, covering 2022-07-20 to 2022-07-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of AD-221 and AD-221A [Phase 3]